Biotechnology - Business Perspectives in Biotechnology

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/32

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:59 PM on 5/12/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

33 Terms

1
New cards

no

Is scientific discovery means successful product?

2
New cards

Scientifically sound and commercially viable

Innovation must be?

3
New cards

Commercialization process

It is the technology transfer process that follows a general pathway to commercialization that may take months or years to come to fruition

4
New cards

In the laboratory

Where does commercialization process begins its journey?

5
New cards

Research and Development

Initial discoveries are made in labs through rigorous scientific knowledge

6
New cards

Proof of concept

Early-stage testing to demonstrate that the technology works as intended

7
New cards

Regulatory approval

Compliance with regulatory bodies like the FDA or EMA ensures safety and efficacy.

8
New cards

Market Analysis

Identifying potential markets, understanding customer needs, and analyzing competitive landscapes.

9
New cards

Funding and investments

Securing financial support through grants, venture capital, or partnerships.

10
New cards

Product Development

Refining the technology for scalability, manufacturability, and usability

11
New cards

Intellectual Property (IP) Management

Protecting innovations through patents and trademarks

12
New cards

Commercial strategy

Developing marketing plans, sales strategies, and distribution channels.

13
New cards

8

How many key steps in commercialization?

14
New cards

Market Analysis

A successful biotech marketing plan relies on a deep, foundational understanding of your specific market and audience

15
New cards

Target market

Refers to the scientific group of customers or users a product is designed for

16
New cards

End users

the final consumers who use a product for its intended purpose

17
New cards

Primary users

are a specific subset of end users who interact with the product most frequently and rely on its core functionalities

18
New cards

Decision-makers

The individuals or entities with the authority to purchase, approve, or renew a product.

19
New cards

Indirect customers

Individuals or entities who receive, distribute, or interact with a product but do not buy it directly from the manufacturer.

20
New cards

Market size

It can be assessed by TAM, SAM, and SOM. When thinking about TAM, SAM, and SOM, try to view them as total potential market, attainable market, and share of the market

21
New cards

TAM

is the total global demand

22
New cards

SAM

is the portion of TAM targeted by your products (someone near the store)

23
New cards

SOM

Is the realistic segment of SAM you can capture, often used for setting sales goals (short-medium term)

24
New cards

Competitor Analysis

The process of identifying and evaluating existing products, technologies, or companies that address the same problem as your biotech innovation

25
New cards

Direct competitor

same product

26
New cards

Indirect competitor

offer different products fulfilling the same need

27
New cards

Future competitor

competitors are companies capable of entering your market

28
New cards

Regulatory considerations

This is major bottleneck in biotech commercialization. No matter how innovative a product is, it cannot reach the market without regulatory approval.

29
New cards

all-time high

Funding for biotechnology is at an?

30
New cards

R&D timelines

Biotech lives in a decade-long gap between discovery and revenue. You aren't just building a product; you are conducting a massive, multi-phase scientific experiment.

31
New cards

Scientific Risk

biology often simply says no

32
New cards

Specialized Infrastructure

You cannot manufacture biologics (like antibodies or cell therapies) in a standard factory.

33
New cards

Regulatory & Intellectual Property (IP)

The "legal" cost of biotech is staggering